88 related articles for article (PubMed ID: 964399)
21. Demonstration of gonadotropin during the second half of the cycle in women using intrauterine contraception.
Beling CG; Cederqvist LL; Fuchs F
Am J Obstet Gynecol; 1976 Jul; 125(6):855-8. PubMed ID: 937412
[TBL] [Abstract][Full Text] [Related]
22. Does the human blastocyst implant in the presence of an IUD?
Res Reprod; 1977 Nov; 9(6):4. PubMed ID: 12260213
[TBL] [Abstract][Full Text] [Related]
23. Human chorionic gonadotropin beta-subunit--like immunoreactive material in the plasma of women wearing an intrauterine progesterone contraceptive system.
Orloff VS; Yamamoto S; Greenwood FC; Bryant-Greenwood GD
Am J Obstet Gynecol; 1979 Jul; 134(6):632-7. PubMed ID: 463954
[TBL] [Abstract][Full Text] [Related]
24. The effect of the copper-T 200 IUD on the luteal phase plasma progesterone concentration in the normal menstrual cycle.
Haukkamaa M; Luukkainen T; Timonen H
Ann Clin Res; 1974 Feb; 6(1):40-4. PubMed ID: 4820609
[TBL] [Abstract][Full Text] [Related]
25. Assessment of human chorionic gonadotropin (HCG) levels during luteal phase in women using intrauterine contraception.
Aubert JM; Boria MC; Stone ML; Reyniak JV
Contraception; 1977 Dec; 16(6):557-62. PubMed ID: 606494
[No Abstract] [Full Text] [Related]
26. Measurement of plasma human chorionic gonadotropin (hCG) and beta-hCG activities in the late luteal phase: evidence of the occurrence of spontaneous menstrual abortions in infertile women.
Chartier M; Roger M; Barrat J; Michelon B
Fertil Steril; 1979 Feb; 31(2):134-7. PubMed ID: 761674
[TBL] [Abstract][Full Text] [Related]
27. Radioreceptorassay of luteinizing hormone-human chorionic gonadotropin in urine: detection of the luteinizing hormone surge and pregnancy.
Saxena BB; Saito T; Said N; Landesman R
Fertil Steril; 1977 Feb; 28(2):163-7. PubMed ID: 832729
[TBL] [Abstract][Full Text] [Related]
28. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
29. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
[TBL] [Abstract][Full Text] [Related]
30. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
[TBL] [Abstract][Full Text] [Related]
31. Application of a radioreceptorassay of human chorionic gonadotropin in the diagnosis of early abortion.
Rosal TP; Saxena BB; Landesman R
Fertil Steril; 1975 Nov; 26(11):1105-12. PubMed ID: 1183637
[TBL] [Abstract][Full Text] [Related]
32. Trophoblastic markers in the differential diagnosis of ectopic pregnancy.
Kauppila A; Rantakylä P; Huhtaniemi I; Ylikorkala O; Seppälä M
Obstet Gynecol; 1980 May; 55(5):560-4. PubMed ID: 6966042
[TBL] [Abstract][Full Text] [Related]
33. Elective removal of an intrauterine device.
Strickler RC
Can Med Assoc J; 1978 May; 118(9):1028, 1031. PubMed ID: 647582
[TBL] [Abstract][Full Text] [Related]
34. Progesterone and estradiol patterns in women using an intrauterine contraceptive device.
Brenner PF; Mishell DR
Obstet Gynecol; 1975 Oct; 46(4):456-9. PubMed ID: 1165881
[TBL] [Abstract][Full Text] [Related]
35. Rapid hCG-specific radioimmunoassay for menstrual aspiration.
Kosasa TS; Pion RJ; Hale RW; Goldstein DP; Taymor ML; Levesque LA; Kobara TY
Obstet Gynecol; 1975 May; 45(5):566-8. PubMed ID: 1124174
[TBL] [Abstract][Full Text] [Related]
36. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
37. Chorionic gonadotropin receptors and immunoreactive chorionic gonadotropin in implantation of the rabbit blastocyst.
Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1984 Feb; 148(4):359-65. PubMed ID: 6320644
[TBL] [Abstract][Full Text] [Related]
38. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
39. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
[TBL] [Abstract][Full Text] [Related]
40. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle.
Turok DK; Godfrey EM; Wojdyla D; Dermish A; Torres L; Wu SC
Hum Reprod; 2013 Oct; 28(10):2672-6. PubMed ID: 23945595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
